ICA Group Wealth Management’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-500
Closed -$8.02K 1196
2024
Q1
$8.02K Hold
500
﹤0.01% 933
2023
Q4
$6.86K Buy
+500
New +$5.73K ﹤0.01% 946
2023
Q3
Sell
-1,800
Closed -$30.6K 985
2023
Q2
$30.6K Buy
1,800
+1,100
+157% +$16.1K 0.01% 597
2023
Q1
$9.78K Hold
700
﹤0.01% 816
2022
Q4
$4.62K Buy
+700
New +$4.2K ﹤0.01% 987

Other funds holding RCEL

ICA Group Wealth Management's RCEL Position: Q2 2024 in Review

ICA Group Wealth Management sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 500 shares — an estimated $8.02K sold.

ICA Group Wealth Management first reported a position in RCEL in Q4 2022 and held it in 5 quarters. The position peaked at $30.6K in Q2 2023. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • ICA Group Wealth Management reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • ICA Group Wealth Management sold 500 Avita Medical shares in Q2 2024, an estimated $8.02K.
  • ICA Group Wealth Management first reported a position in Avita Medical in Q4 2022 and held it in 5 quarters.
  • ICA Group Wealth Management's Avita Medical position peaked at $30.6K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on ICA Group Wealth Management's 13F filing for Q2 2024, filed 8 Aug 2024.